GPT and metabolic dysfunction-associated steatotic liver disease: In the full model, with further adjustment for all lifestyle habits, which were associated with sRAGE (Table 2), low sRAGE levels were associated with elevated ALT (OR = 1.69, 1.11–2.57, P = 0.014), and significant dose-response association was demonstrated between serum sRAGE levels and NAFLD with elevated ALT (Table 3, model B).